COSCIENS Biopharma Inc. CSCI.TO

CSCI.TO Company Overview

COSCIENS Biopharma Inc. (TSX: CSCI) is a Canadian biotechnology and life sciences company focused on the development, commercialization, and licensing of health-related products and technologies spanning biopharmaceuticals, nutraceuticals, and active ingredient platforms. The company emerged through the combination of legacy biotechnology and health-science businesses, including operations historically associated with Aeterna Zentaris and Ceapro Inc., and has positioned itself around specialty health products, enabling technologies, and intellectual property commercialization.

The company’s activities have included drug development programs, proprietary extraction and processing technologies, and the commercialization of bioactive compounds used in healthcare, skincare, and wellness applications. COSCIENS primarily serves pharmaceutical, health-product, and specialty ingredient markets in North America and selected international regions. Its strategic positioning has centered on leveraging proprietary research capabilities, manufacturing know-how, and intellectual property portfolios to pursue diversified life sciences revenue streams. Certain operational and product-line details remain subject to ongoing integration and corporate restructuring disclosures in public filings.